Catalyst Wire Dossier Catalyst Wire Dossier

Erdafitinib

erdafitinib · Janssen Research & Development, LLC
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Erdafitinib, covering 2023-09-28 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder Cancer [Phase 1]

See pricing